KBC Group NV Boosts Stock Position in Doximity, Inc. (NASDAQ:DOCS)

KBC Group NV raised its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 22.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 3,296 shares of the company’s stock after acquiring an additional 614 shares during the quarter. KBC Group NV’s holdings in Doximity were worth $144,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently modified their holdings of the business. William Blair Investment Management LLC lifted its position in shares of Doximity by 15.8% during the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock worth $179,122,000 after acquiring an additional 873,682 shares in the last quarter. Clearbridge Investments LLC lifted its holdings in Doximity by 7.1% during the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock worth $163,709,000 after purchasing an additional 387,200 shares in the last quarter. Swedbank AB bought a new position in Doximity in the 1st quarter worth about $91,673,000. Janus Henderson Group PLC grew its holdings in Doximity by 33.5% during the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock valued at $66,594,000 after buying an additional 621,590 shares in the last quarter. Finally, Capital World Investors increased its position in shares of Doximity by 250.7% during the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock valued at $46,143,000 after buying an additional 1,225,707 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on DOCS shares. Evercore ISI upped their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Baird R W raised shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Barclays raised their target price on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and upped their target price for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. Finally, Truist Financial upped their target price on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Eleven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Doximity currently has an average rating of “Hold” and an average price target of $52.27.

Doximity Stock Performance

DOCS opened at $48.00 on Friday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The stock has a market capitalization of $8.96 billion, a price-to-earnings ratio of 55.17, a PEG ratio of 4.18 and a beta of 1.30. The company has a fifty day moving average of $44.47 and a two-hundred day moving average of $34.84.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.